Winds Of Change In World OTC Health Care Market

15 December 1997

Sales of over-the-counter indigestion remedies will grow over 28%between 1997 and 2001, according to a new report from Euromonitor, which points out that this is much faster than any other sector of the world OTC health care market, for which growth of 20% is forecast over this period.

While showing the fastest growth, digestive remedies will remain the smallest OTC category, with 1997 sales of $7.5 billion moving up to $9.6 billion in 2001.

The largest segment, dietary supplements, had 1997 turnover of $10.8 billion, with 17.9% growth pushing this up to $12.7 billion by 2001. Medicated skin care products will increase 20.5% from $9.6 billion to $11.6 billion, cough and cold remedies will grow 17.1% from $9.1 billion to $10.7 billion, and analgesics will expand 17.1% from $8.7 billion of $10.1 billion, says Euromonitor.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight